KREF Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

GAAP Loss: $122 million, or negative $1.95 per share.

Book Value: Declined to $10.24 per share, a 13.7% decrease from the previous quarter.

Distributable Loss: $36 million, or negative $0.58 per share.

Distributable Earnings Before Realized Losses: $6 million, or $0.10 per share, covering the quarterly dividend of $0.10.

Repayments: Over $800 million received during the quarter; total repayments expected to exceed $2 billion for the year.

Liquidity: Over $700 million available, including $83 million in cash and $350 million in undrawn revolver capacity.

Debt-to-Equity Ratio: 2.6x, with total leverage at 4.3x.

2Strategic Updates and Business Highlights

Strategic Alternatives Review: KREF's Board has initiated a review of strategic alternatives to enhance shareholder value, led by an independent committee. No proposals have been submitted by KKR as of now.

Portfolio Repositioning: Focus on reducing legacy office exposure (down to 18% from 21%) and targeting below 10% by year-end 2026. Watch list assets represent 16% of the portfolio, with plans to reduce this by year-end.

New Originations: Loans originated from 2024 to 2026 now comprise 32% of the portfolio, with a goal to exceed 50% by year-end.

Asset Monetization: Progress in monetizing watch list assets and REO portfolio, with significant actions taken to position these for sale.

3Forward Guidance and Outlook

Earnings Expectations: Anticipated earnings to trough later in 2026, with expectations for stability and recovery in book value thereafter.

Dividend Coverage: Continuing to expect $0.40 per year in dividends to be covered by annual distributable earnings before realized losses.

Capital Allocation: Future decisions on share repurchases will be influenced by the strategic review process, but repurchases are not precluded during this time.

4Bad News, Challenges, or Points of Concern

Significant Losses: The company reported a substantial GAAP loss and a notable decline in book value, indicating challenges in asset valuations.

Legacy Asset Exposure: Continued exposure to legacy office assets and watch list loans presents ongoing risks.

Market Conditions: The commercial real estate market remains under pressure, particularly in the multifamily sector, with concerns about rising interest rates and excess supply impacting valuations.

Downgrades: Several loans were downgraded in risk ratings, reflecting increased credit risk and potential losses.

5Notable Q&A Insights

Book Value Stability: Management expressed confidence that the most significant impacts on book value are behind them, although some variability may still occur as asset resolutions progress.

Capital Allocation Priorities: Management indicated that share buybacks and new originations will be evaluated based on leverage ratios and repayment activity, with a focus on maintaining a balanced approach.

Life Science Sector: Discussions around the Life Science portfolio highlighted ongoing modification efforts, with management believing they are fully reserved on certain loans.

Market Trends: Management acknowledged the current softness in the multifamily market but expressed optimism for recovery in the coming quarters, driven by improved absorption rates. Overall, KREF is navigating a challenging environment with strategic initiatives aimed at enhancing shareholder value while addressing portfolio risks.